enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Febuxostat - Wikipedia

   en.wikipedia.org/wiki/Febuxostat

   Febuxostat, sold under the brand name Uloric among others, is a medication used long-term to treat gout due to high uric acid levels. [7] It is generally recommended only for people who cannot take allopurinol. [8] [9] It is taken by mouth. [7] Common side effects include liver problems, nausea, joint pain, and a rash. [7]

3. Your Gout Guide: From Symptoms to Treatment - AOL

   www.aol.com/gout-guide-symptoms-treatment...

   Taking certain types of medications can contribute to gout. A couple examples include cyclosporine, an immunosuppressant drug, and diuretics. Lastly, dietary factors also increase gout risk ...

4. Allopurinol - Wikipedia

   en.wikipedia.org/wiki/Allopurinol

   Allopurinol is used to reduce urate formation in conditions where urate deposition has already occurred or is predictable. The specific diseases and conditions where it is used include gouty arthritis, skin tophi, kidney stones, idiopathic gout; uric acid lithiasis; acute uric acid nephropathy; neoplastic disease and myeloproliferative disease with high cell turnover rates, in which high urate ...

5. Colchicine - Wikipedia

   en.wikipedia.org/wiki/Colchicine

   Colchicine is a medication used to prevent and treat gout, [3] [4] to treat familial Mediterranean fever [5] and Behçet's disease, [6] and to reduce the risk of myocardial infarction. [7] The American College of Rheumatology recommends colchicine, nonsteroidal anti-inflammatory drugs (NSAIDs) or steroids in the treatment of gout.

6. Category:Antigout agents - Wikipedia

   en.wikipedia.org/wiki/Category:Antigout_agents

   Generally, drugs outlined within the ATC code M04 should be included in this category. Please see WP:PHARM:CAT for more information. Wikimedia Commons has media related to Antigout agents .

7. Dotinurad - Wikipedia

   en.wikipedia.org/wiki/Dotinurad

   Dotinurad (Urece) is a drug for the treatment of gout and hyperuricemia. [1] [2] It was developed by Fuji Yakuhin and approved for use in Japan in 2020. [2] [3] The drug is continuing clinical trials by Fortress Biotech and regulatory evaluation for approval in North America and Europe. [3] [4]